Cargando…

The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation

Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naïve NK cells is fundamentally triggered by cytokines or myel...

Descripción completa

Detalles Bibliográficos
Autores principales: Azuma, Masahiro, Sawahata, Ryoko, Akao, Yuusuke, Ebihara, Takashi, Yamazaki, Sayuri, Matsumoto, Misako, Hashimoto, Masahito, Fukase, Koichi, Fujimoto, Yukari, Seya, Tsukasa
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932735/
https://www.ncbi.nlm.nih.gov/pubmed/20824059
http://dx.doi.org/10.1371/journal.pone.0012550
_version_ 1782186098112331776
author Azuma, Masahiro
Sawahata, Ryoko
Akao, Yuusuke
Ebihara, Takashi
Yamazaki, Sayuri
Matsumoto, Misako
Hashimoto, Masahito
Fukase, Koichi
Fujimoto, Yukari
Seya, Tsukasa
author_facet Azuma, Masahiro
Sawahata, Ryoko
Akao, Yuusuke
Ebihara, Takashi
Yamazaki, Sayuri
Matsumoto, Misako
Hashimoto, Masahito
Fukase, Koichi
Fujimoto, Yukari
Seya, Tsukasa
author_sort Azuma, Masahiro
collection PubMed
description Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naïve NK cells is fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S-[2,3-bis(palmitoyl)propyl]cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK cell activation was evaluated by three criteria: IFN-γ production, up-regulation of NK activation markers and cytokines, and NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence. Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides critically affects the potential for NK activation.
format Text
id pubmed-2932735
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29327352010-09-07 The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation Azuma, Masahiro Sawahata, Ryoko Akao, Yuusuke Ebihara, Takashi Yamazaki, Sayuri Matsumoto, Misako Hashimoto, Masahito Fukase, Koichi Fujimoto, Yukari Seya, Tsukasa PLoS One Research Article Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naïve NK cells is fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S-[2,3-bis(palmitoyl)propyl]cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK cell activation was evaluated by three criteria: IFN-γ production, up-regulation of NK activation markers and cytokines, and NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence. Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides critically affects the potential for NK activation. Public Library of Science 2010-09-02 /pmc/articles/PMC2932735/ /pubmed/20824059 http://dx.doi.org/10.1371/journal.pone.0012550 Text en Azuma et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Azuma, Masahiro
Sawahata, Ryoko
Akao, Yuusuke
Ebihara, Takashi
Yamazaki, Sayuri
Matsumoto, Misako
Hashimoto, Masahito
Fukase, Koichi
Fujimoto, Yukari
Seya, Tsukasa
The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
title The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
title_full The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
title_fullStr The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
title_full_unstemmed The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
title_short The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
title_sort peptide sequence of diacyl lipopeptides determines dendritic cell tlr2-mediated nk activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932735/
https://www.ncbi.nlm.nih.gov/pubmed/20824059
http://dx.doi.org/10.1371/journal.pone.0012550
work_keys_str_mv AT azumamasahiro thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT sawahataryoko thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT akaoyuusuke thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT ebiharatakashi thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT yamazakisayuri thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT matsumotomisako thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT hashimotomasahito thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT fukasekoichi thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT fujimotoyukari thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT seyatsukasa thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT azumamasahiro peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT sawahataryoko peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT akaoyuusuke peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT ebiharatakashi peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT yamazakisayuri peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT matsumotomisako peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT hashimotomasahito peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT fukasekoichi peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT fujimotoyukari peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation
AT seyatsukasa peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation